PERCEPTIVE ADVISORS LLC 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-16 3:57 pm Sale |
2020-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
PERCEPTIVE ADVISORS LLC | 2,577,043 4.300% |
-676,880![]() (-20.80%) |
Filing |